GlassScriptPhysician profile
Jourdan Daria Milliard
NPI 1629638879
$12,549.50
in general payments reported to CMS, 2019-2025
8 companies · $23.35 in 2025
The $23.35 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $197 · 2023: $10K · 2024: $2,094 · 2025: $23.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $9,000 · Travel and Lodging: $2,175 · Food and Beverage: $1,178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $9,000.00 |
| Travel and Lodging | $2,175.08 |
| Food and Beverage | $1,177.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amylyx Pharmaceuticals, INC. | $11,882.55 | 2023-2024 | Relyvrio |
| Biogen, INC. | $193.94 | 2022-2023 | Spinraza |
| Alexion Pharmaceuticals, INC. | $165.75 | 2023-2025 | Ultomiris |
| Genentech, INC. | $116.15 | 2023 | Evrysdi |
| Genzyme Corporation | $98.35 | 2023 | |
| Edw Pharma, INC. | $38.48 | 2024 | Tiglutik |
| Phenox INC. | $33.51 | 2022 | |
| Electromed, INC. | $20.77 | 2024 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jourdan Milliard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.